chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving 2nd Vaccine, next morning I had very swollen and a painful knot at injection site, flu like symptoms as provider told me might occur, then on March 1, 2020, I starting having severe symptoms in which I was unable to go to work.  I had A SEVERE migraine level 10 pain, severe joint pain all over body level 10 pain, dizziness, eyes burning, blurred vision, chills, extremely fatigued.  Called PCP for doctor appointment. Went for doctor visit and told him all my symptoms, He was very concerned I had a reaction to vaccine.   He prescribed prednisone 7 day pack for severe joint pain & inflammation, Nurtec disintegrating tablets, meloxicam, ordered bloodwork and had follow up in 2 weeks, after two weeks symptoms were still the same very severe, he referred me to Neurologist for evaluation, she ordered MRI as a stat to be done right away,  and started me on meds for Severe Migraines and sent me to Ophthalmologist, she had a nurse get me an appointment the next day.   I saw Ophthalmologist the very next day he did workup and diagnostic testing in his office and stated I had severe swelling and inflammation in the optic nerves in both eyes, and referred me and sent records to Dr., Neuro Ophthalmologist and contacted their office to get me in right away.  I had my appointment with Dr. and she has ordered an ultrasound of my eyes by retina specialist which appointment is in June.  I have follow up with her after ultrasound is done.  Due to severe joint pain I am still having my PCP has referred me to a rheumatologist.  My pain is severe.  The vaccine has attacked my immune system.  Doctors and specialists are doing everything possible and I am still off work.  My return to work date has not been determined.
Patient mistakenly received a flu shot- she had received this years formulation last month - then she received the PNEUMOVAX. The next day she reported a very red and swollen arm where she received the vaccines. The next day she said the area of redness and swelling is continuing to spread.
Yellow Fever vaccine given SQ in left arm.  Almost immediately patient began C/O itching at site.  Area became red and began to swell.  Patient began C/O thickness in her throat.  Benadryl given.  HR and BP elevated.  Patient C/O itching/tingling in mouth and throat.  Skin pale and clammy.  Unable to get pulse ox reading.  Patient visibly anxious.  Consented to receiving epipen injection.  Escorted by EMS to ambulance to the ER.
I tested positive for COVID on Feb. 1, 2023. My head was really congested, and I had body aches, both my head and chest were congested. The second day I started getting chills, and the third day went away, fourth day still congested. Since it's been over seven day I tested again, and it was negative. I called my doctor and let them I tested positive, and they prescribed me Paxlovid, but I didn't take it.
second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes; No adverse event; second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes), PRODUCT TEMPERATURE EXCURSION ISSUE (second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes) and NO ADVERSE EVENT (No adverse event) in a 20-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 011H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes), PRODUCT TEMPERATURE EXCURSION ISSUE (second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes) and PRODUCT TEMPERATURE EXCURSION ISSUE (second excursion details requested:lot#011H22A12/29/2022 -excursion time:90minutes,12/30/2022: excursion:140 minutes).    No concomitant medications were reported. It was reported that vaccine received and stored at 36f to 46f in refrigeration on 05-Dec-2022. No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-694885 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 04-Jan-2023: Non-significant follow-up appended; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-694885:Same reporter
5 patients who got the Moderna booster after the vial was already punctured 20 times; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTRATION ERROR (5 patients who got the Moderna booster after the vial was already punctured 20 times) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939930) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT ADMINISTRATION ERROR (5 patients who got the Moderna booster after the vial was already punctured 20 times). On 21-Dec-2021, PRODUCT ADMINISTRATION ERROR (5 patients who got the Moderna booster after the vial was already punctured 20 times) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that 25 booster doses were administered intramuscularly in the upper deltoid from 1 vial of Moderna vaccine, which was removed from refrigerator storage at 10am for first puncture and had a last puncture at 4pm.  Administration error was reported to VAERS 752534.  Concomitant medication information was not reported  Treatment information was not reported
This case was considered medically important. Information regarding PREVNAR was received from a consumer regarding a patient who developed autism. The patient received a dose on an unspecified date. It was reported that the patient, a child, is autistic. The outcome was not specified. No additional information was available at the time of this report.
pt rcvd vax; w/in 24 hrs of 2nd dose; pt devel erythema & rash on face; pt exp malaise; achy joints; muscles aches; generalized weakness; flushing & t 101;
My son started to complain of pain in his rt. arm below the injection site (just above the bend in his elbow).   When I looked at it, there was a "bump"  under his skin at the location. It was approximately 0.5 inches in diameter.  It was not warm to touch, but his stated it was painful.   The next morning the "bump" was a bit larger and hard.  As of the writing of this report, it  has grown larger and we followed up with his PCP.
A booster was administered to a patient to a underaged patient.; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A booster was administered to a patient to a underaged patient.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A booster was administered to a patient to a underaged patient.). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A booster was administered to a patient to a underaged patient.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drugs were reported. No treatment drugs were reported.
1) fatigue- began about 12 hours after dose, moderate/severe, still present 48 hours after dose 2) headache- began about 18 hours after dose, mild, resolved about 24 hours after onset 3) body aches- began about 18 hours after dose, moderate, still present 48 hours after dose 4) red painful, swollen patch on arm at injection site- began about 36 hours after dose, painful to the touch, painful when arm is at rest, still present 48 hours after dose 5) chest tightness- very mild, began  12 hours after dose, resolved within 24 hours 5) fever - began 12 hours after dose, 102 degrees on fever-reducing medication, shaking chills and fever sweats, fever still present after 48 hours, but not as high 6) sore throat - began 24 hours after dose, mild, still present 48 hours after dose
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history, drug reactions and allergies were not provided. On 08-MAY-2017, the patient was vaccinated with a first dose of GARDASIL 9 (strength, dose, frequency, route of administration, lot# and expiration date were not reported). On 14-NOV-2017, the patient was vaccinated with the second dose of GARDASIL 9 (strength, dose, frequency, route of administration, lot# and expiration date were not reported. No adverse effects were reported.
This spontaneous case was reported by a nurse and describes the occurrence of PERICARDITIS (Seen a lot of pericarditis cases in both young and old people) and HYPERTENSIVE CRISIS (Seeing more cases of a hypertensive crisis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERICARDITIS (Seen a lot of pericarditis cases in both young and old people) (seriousness criterion medically significant) and HYPERTENSIVE CRISIS (Seeing more cases of a hypertensive crisis) (seriousness criterion medically significant). At the time of the report, PERICARDITIS (Seen a lot of pericarditis cases in both young and old people) and HYPERTENSIVE CRISIS (Seeing more cases of a hypertensive crisis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On 10/27/00, pt presented to ER with complaint of non-radiating chest pain and numbness of fingers and toes. Discharged after 23 hours observation. To follow-up with her own physician. On 11/2/00, admitted to hospital for progressive worsening weakness, starting from the lower extremities to the trunk and upper chest. R/o Guillain-Barre. The follow-up reports states that the pt had similar experience in 1999 after her first exposure to flu shot.
patient felt more pain then usual at time of injection, after injection patients upper left arm was painful, pain started radiating into her back witch led to swelling, pain also radiated into her neck and down into her arm. This is a burning pain. Pain started at time of injection to present.
big dark blood spots in arms and legs; feels tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PURPURA (non-serious), outcome "unknown", described as "big dark blood spots in arms and legs"; FATIGUE (non-serious), outcome "unknown", described as "feels tired".  Additional information: Patient stated she is having big dark blood spots in arms and legs after taking the COVID vaccine and feels tired and added that, before taking the COVID vaccine, she was getting blood spots as well, but just not as dark and big.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
lt deltoid red w/itch sensation, mild warmth to touch, mild pain w/movement;
Covid arm. Red, swelling, large bump., hot, sore. Called clinic told it was probably nothing. CDC website said go to dr or ER.   Dr there glanced at my arm and said it was an infection  and gave me antibiotic, Cephalexin 500mg, 10 days.  Feel really bad but maybe better today and that  is after tramadol and tylenol. Headaches. Tylenol helps.. now afraid to take 2nd shot.
Patient was given the adult dose TDaP when he should have received the pediatric dose of DTaP. There are not any reported adverse reactions at this time.
Patient received a dose of Meningococcal Conjugate vaccine, per medical assistant no adverse reaction was noted at the time of administration. Patient was notified of incident, and he has not reported any adverse reactions as of yet.
4AUG acute onset "stocking numbness" right leg progressing up into hip; went to ER; no tx; numbness dec; pt saw neurologist & had numerous tests (Lyme test); MRI of neck & upper thoracic - all neg; dx: myelitis secondary tetanus vaxs;
anaphylactic shock; difficulty breathing; throat swelling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 immunization; Bnt162b2 (Dose 2, single), for COVID-19 immunization. The following information was reported: ANAPHYLACTIC SHOCK (hospitalization), outcome "unknown", described as "anaphylactic shock"; DYSPNOEA (non-serious), outcome "unknown", described as "difficulty breathing"; PHARYNGEAL SWELLING (non-serious), outcome "unknown", described as "throat swelling". Therapeutic measures were taken as a result of anaphylactic shock.  Clinical course: The patient was at a health facility getting the shot and instantly afterwards he started to get anaphylaxis. So, they had to inject him, call an ambulance, treat him at the hospital and then they watched him for a few hours, and they released him. He had to take a ride in an ambulance. The lot number for bnt162b2 was not provided and will be requested during follow up.
Information has been received from a pharmacist concerning a male patient (age not reported) who was vaccinated (date not reported) subcutaneously with the first 0.5ml dose of PNEUMOVAX 23 (lot# 658074/0961U). Subsequently, the patient developed cellulitis. The patient had an office visit and received medical treatment with unspecified antibiotics and anti-inflammatories. At the time of this report the outcome was unknown. The pharmacist requested a lot check for PNEUMOVAX 23 (lot# 658074/0961U). A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the government and was released. This is one of several reports from the same source. Additional information has been requested.
It started with on-going muscle aches and stiffness in my arms from elbow through fingers and legs from knee through feet. Experience has taught me that this means my thyroid meds were not as effective, This continued for almost 2 months. It finally seemed to be resolved but 5 days later I started with itching and hives on my body and particularly face and head within 30 minutes after taking my thyroid medicine which i take 4 times a day. It feels like there is a small bug or hair rubbing against my skin. This continues through today making it difficult to sleep for more than an hour at a time. It seems to me that this mRNA vaccine is blocking my thyroid medication from being taken up by the muscle cells.  Taking an antihistamine lessens the itch but then messes with my head because of my age.  I cannot live without my thyroid medication. Now what do I do???
Medication Administration Error. Patient received 0.25 mL of Moderna bivalent vaccine on 09/20/2022 instead of 0.5 mL. Once error was discovered, the patient was contacted and returned to the clinic shortly afterwards to receive 0.25 mL more for a full dose.
This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (had no appetite), PAIN (her body ached very bad, like she got ran over), FATIGUE (feeling fatigue), HEADACHE (very bad headache) and NAUSEA (she felt nauseous) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced FATIGUE (feeling fatigue) and HEADACHE (very bad headache). On 28-Apr-2021, the patient experienced PAIN (her body ached very bad, like she got ran over). On 29-Apr-2021, the patient experienced DECREASED APPETITE (had no appetite) and NAUSEA (she felt nauseous). At the time of the report, DECREASED APPETITE (had no appetite), PAIN (her body ached very bad, like she got ran over), FATIGUE (feeling fatigue), HEADACHE (very bad headache) and NAUSEA (she felt nauseous) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, COVID-19: other (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment information not provided. No concomitant medications were reported
Excessive somnolence slept 24 hrs w/brief periods awake (20 minutes) for breastfeding only; not reported until 23OCT91;
pt recv vax 27MAY95  following a cut shin on a metal banister;MD visit 31MAY dx mild, local cellulitis @ inj site;ATB, DPH, warm compresses & elevation of leg prescribed;
No adverse event noted. Patient was due for third vaccine. Administered vaccine 1/13/2022. Wife brought card into clinic on 3/28/22 and noted pt received a previous booster in 12/2021 from a different facility.
Pt complained of redness, swelling, warm to the touch and pain in the arm where injection was given for about 3 days. No treatment given.
Vaccine administered 06/18/15 on 6/23/15, injection site painful, w/ central erythema approximately 4mm. No treatment other than warm packs.
Im very healthy,  haven't been sick in 10+ years, workout, eat clean , have very good hygeine. 4 hours after injection I had shakes and shivers where I felt like I was freezing inside. 7 hours after the injection the shakes and shivers increasing got worse and with them came terrible muscle aches and following that a terrible headache started and with each hour proceeded to get worse to the point of being practically unbearable.  10 hours after a fever insued and I began hallucinating and could hardly stand up without falling over. 24 hours later the hallucinations and shaking stopped but the headache, muscle aches, and shivers persisted for 3 more days and I felt incredibly weak. A full week after the injection I feel fine and am back to normal and do not seem to have any lasting symptoms.
Pt noted discomfort along the medial rt leg the morning after her vaccination. This progressed to red streaking (lymphangitis) within 48-72 hours. Venous duplex negative for superficial thrombophlebitis. The pt then developed shingles in same extremity at day 14 following the vaccination.
about an hour after vaccine administration (at 4:30pm) client began having a fever. Mother medicated with Tylenol. At 6pm the same day child refused dinner and Tylenol didn't break fever. Mother medicated with ibuprofen. child began complaining of stomach pain and inability to eat. At 10pm he complained of neck pain and inability to turn neck. At 2:30 AM on 9.15.19 he began vomiting and crying unconsolably. He was taken to local ER and later released same day. Mother reports when fever drops his stiff painful neck goes way and when fever spikes it hurts again. Highest temp 102.2 F. Client currently managed on Tylenol every four hours and out of school 9.16.19.
On 02/21/2003 1pm, developed fever 102 degrees F. Given Motrin and Tylenol by mother on 02/22/2003 1am. Had vomiting and fever 103 degrees F with convulsions. Went to ER. Fever was 102 degrees F with Tylenol 94 degrees and Motrin 96 degrees.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 16May2021 as dose 2, single (Batch/Lot number: unknown) at the age of 28 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "sulfa allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: patient received paxlovid on 21Apr2023 to 25Apr2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300183108 same reporter/patient, different drug/AE;
Diagnosed with neuroblastoma on 3/13 and started on chemotherapy on 3/18. Admitted at Hospital. Rash starting near left eye on 3/27 then disseminated to entire body over next 1-2 days. Started on acyclovir on 3/28. Remains on acyclovir because of continued chemotherapy.